Type 1 diabetes refers to the hyperglycemia resulting from a total absence of insulin secretion; meanwhile, T2DM consists of the resistance or inability to utilize insulin by the peripheral tissues and inadequate compensatory secretion of insulin; α-amylase and α-glucosidase inhibition is a suitable remedy to T2DM [6]. Here, INS is linked to type 1 diabetes mellitus.